Weak clinical effect of airway clearance on ADH and BNP concentration: mechanism or data collection BIAS.
作者信息
de Melo Mateus Augusto Felix, de Melo Pâmela Marillac Rodrigues Feijó, Gonçalves Ially Raissa de Sá, Marques Cecília Beatriz Gomes, Bezerra Beatriz Santos Moraes da Cunha, Lopes Johnnatas Mikael
机构信息
Centro Universitário Uninassau, Paulo Afonso, BA, Brasil.
Universidade Federal do Vale do São Francisco - UFVSF, Petrolina, Pernambuco, Brasil.
出版信息
Int Braz J Urol. 2023 Jul-Aug;49(4):523-524. doi: 10.1590/S1677-5538.IBJU.2023.0138.
Abstract
摘要
相似文献
1
Weak clinical effect of airway clearance on ADH and BNP concentration: mechanism or data collection BIAS.
Int Braz J Urol. 2023 Jul-Aug;49(4):523-524. doi: 10.1590/S1677-5538.IBJU.2023.0138.
2
Timing of dornase alfa inhalation for cystic fibrosis.
Cochrane Database Syst Rev. 2011 May 11(5):CD007923. doi: 10.1002/14651858.CD007923.pub2.
3
Timing of dornase alfa inhalation for cystic fibrosis.
Cochrane Database Syst Rev. 2013 Jun 5(6):CD007923. doi: 10.1002/14651858.CD007923.pub3.
4
Timing of dornase alfa inhalation for cystic fibrosis.
Cochrane Database Syst Rev. 2016 Jul 26;7(7):CD007923. doi: 10.1002/14651858.CD007923.pub4.
5
Enuresis and upper airway obstruction: BNP and ADH hormones behavior before and after airway surgery.
Int Braz J Urol. 2022 Nov-Dec;48(6):937-943. doi: 10.1590/S1677-5538.IBJU.2022.0313.
6
Adenotonsillectomy Normalizes Hormones and Urinary Electrolytes in Children With Nocturnal Enuresis and Sleep-Disordered Breathing.
Urology. 2015 Jul;86(1):158-61. doi: 10.1016/j.urology.2015.04.011.
7
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
Cochrane Database Syst Rev. 2019 Nov 27;2019(11):CD003147. doi: 10.1002/14651858.CD003147.pub5.
8
Oscillating devices for airway clearance in people with cystic fibrosis.
Cochrane Database Syst Rev. 2020 Apr 30;4(4):CD006842. doi: 10.1002/14651858.CD006842.pub5.
9
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Cochrane Database Syst Rev. 2015 Mar 26(3):CD009841. doi: 10.1002/14651858.CD009841.pub2.
10
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Cochrane Database Syst Rev. 2019 Jan 7;1(1):CD009841. doi: 10.1002/14651858.CD009841.pub3.
本文引用的文献
1
Enuresis and upper airway obstruction: BNP and ADH hormones behavior before and after airway surgery.
Int Braz J Urol. 2022 Nov-Dec;48(6):937-943. doi: 10.1590/S1677-5538.IBJU.2022.0313.
2
Brazilian consensus in enuresis-recomendations for clinical practice.
Int Braz J Urol. 2019 Sep-Oct;45(5):889-900. doi: 10.1590/S1677-5538.IBJU.2019.0080.
3
Pelvic floor muscle training alone or in combination with oxybutynin in treatment of nonmonosymptomatic enuresis. A randomized controlled trial with 2-year follow up.
Einstein (Sao Paulo). 2019 Jun 27;17(3):eAO4602. doi: 10.31744/einstein_journal/2019AO4602.
4
Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.
Front Psychol. 2013 Nov 26;4:863. doi: 10.3389/fpsyg.2013.00863.
5
Nocturnal enuresis: an international evidence based management strategy.
J Urol. 2004 Jun;171(6 Pt 2):2545-61. doi: 10.1097/01.ju.0000111504.85822.b2.
Zotero 插件